title_logo menu_logo
twitter
menu_bg




funding_banner

resources_banner
newsletter_banner


Interested in receiving DiaComp News/Updates?





news

login_banner
Email Address:
Password:

Request Account

If you have forgotten your password please enter your email address and click
Forget Password?

resources_banner

We need your help identifying important research questions in complications research. DiaComp supports an interactive web-based dialogue that allows users to submit ideas, vote on existing ideas, or add comments. The results will help us identify future research opportunities. Click Here

Investigator Highlights
resources_banner

Uncomplicating Diabetes: Reducing the Burden of Diabetes Related End-Organ Injury

February 25—March 1, 2018

CLICK HERE FOR MORE INFO INCLUDING DEADLINES


Welcome to DiaComp

The goal of the NIDDK-sponsored Diabetic Complications Consortium (DiaComp) is to advance the study of diabetic complications and promote communication and collaboration between investigators involved in complications research. Toward this goal, DiaComp will:
  1. sponsor annual meetings in complications-relevant scientific areas;
  2. solicit and fund pilot projects in high impact areas of complications research;
  3. support a website to serve the diabetic complications community.

Whats_New


ACCELERATING MEDICINES PARTNERSHIP (AMP)
The NIH, 10 biopharmaceutical companies, and multiple non-profit organizations recently launched the Accelerating Medicines Partnership (AMP) to identify and validate the most promising biological targets for therapeutics. All AMP data is considered precompetitive and made publicly accessible to the broad biomedical community for further research.
Click Here

New data from the Chronic Renal Insufficiency Cohort (CRIC) study has been added to the NIDDK Repository
Data from the recruitment and follow-up phases of the study through 3/31/2013 are now available. The data package now includes variables related to APOL1, Echocardiogram, Electrocardiogram, and censored composite and individual outcomes. If you have additional questions, please contact: Dr. Rebekah Rasooly, (Rebekah.rasooly@nih.gov)
Click Here

International Mouse Phenotype Consortium (IMPC)
The goal of the International Mouse Phenotyping Consortium (IMPC) is to discover functional insight for every gene by generating and systematically phenotyping 20,000 knockout mouse strains. The IMPC is generating a knockout mouse strain for every protein coding gene by using the embryonic stem cell resource generated by the International Knockout Mouse Consortium (IKMC). The production of mouse strains from these ES cells are tracked within the "international Micro-injection tracking system" (iMits) and are made available to the research community via public repositories. Systematic broad-based phenotyping is performed by each IMPC center using standardized procedures found within the International Mouse Phenotyping Resource of Standardised Screens (IMPReSS) resource. Gene-to-phenotype associations are made by a versioned statistical analysis with all data freely available. DiaComp has developed an interface to search the the IMPC data by gene symbol, phenotype or procedure/test done on the mice. Click the link below to go to the search page.
Click Here

 
Please acknowledge all posters, manuscripts or scientific materials that were generated in part or whole using funds from the Diabetic Complications Consortium(DiaComp) using the following text:

Financial support for this work provided by the NIDDK Diabetic Complications Consortium (DiaComp, www.diacomp.org), grants DK076169 and DK115255

diacomp_logo

Citation text and image have been copied to your clipboard. You may now paste them into your document. Thank you!